![]() |
|
|
Vol. 294, Issue 1, 117-125, July 2000
Division of Pharmaceutics, College of Pharmacy (S.-N.H., P.W.S.),
and The Ohio State Biophysics Program (P.W.S.), The Ohio
State University, Columbus, Ohio
This study addresses the transport mechanism of riboflavin (vitamin
B2) across intestinal epithelium in the presence and
absence of pharmacologically active compounds. A polarized transport
process with a 6-fold higher basolateral (BL)-to-apical (AP) flux was observed in both a human intestinal cell model (Caco-2) and rat intestinal tissue. Riboflavin-specific translocation systems on both
the AP and BL cell surfaces were saturable with affinity values
close to most receptors (Km: 9.72 ± 0.85 and 4.06 ± 0.03 nM, respectively). Pharmacological agents
known to alter intracellular endocytic events were used to examine the
potential involvement of receptor-mediated events. Nocodazole
significantly inhibited AP uptake (58.4%), BL-to-AP riboflavin
(56.7%) and fluorescein isothiocyanate-labeled transferrin
(FITC-Tf) (31.8%) transport without affecting mannitol or cholic acid
transport, whereas AP-to-BL riboflavin (252.8%) and FITC-Tf (145.1%)
transport was increased. Brefeldin A significantly enhanced AP-to-BL
riboflavin (37.1%) and bidirectional FITC-Tf transport (AP-to-BL:
13-fold; BL-to-AP: 5-fold). without affecting BL-to-AP riboflavin
transport. Combined, these data suggest an essential role of
microtubule-dependent movement and vesicular sorting component(s) in
the bidirectional transport of riboflavin. Dissociation of riboflavin
from the cell surface was pH-dependent with significantly higher
substrate release at acidic pH, indicating the presence of
riboflavin-specific cell surface receptors. In summary, our studies
provide biochemical evidence of the involvement of a receptor-mediated
mechanism in the cellular translocation of riboflavin.
This article has been cited by other articles:
![]() |
A. Yonezawa, S. Masuda, T. Katsura, and K.-i. Inui Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1 Am J Physiol Cell Physiol, September 1, 2008; 295(3): C632 - C641. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Foraker, A. Ray, T. C. Da Silva, L. M. Bareford, K. M. Hillgren, T. D. Schmittgen, and P. W. Swaan Dynamin 2 Regulates Riboflavin Endocytosis in Human Placental Trophoblasts Mol. Pharmacol., September 1, 2007; 72(3): 553 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. van Herwaarden, E. Wagenaar, G. Merino, J. W. Jonker, H. Rosing, J. H. Beijnen, and A. H. Schinkel Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk Mol. Cell. Biol., February 15, 2007; 27(4): 1247 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Mason, V. M. D'Souza, L. M. Bareford, M. A. Phelps, A. Ray, and P. W. Swaan Recognition, Cointernalization, and Recycling of an Avian Riboflavin Carrier Protein in Human Placental Trophoblasts J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Huang, M. A. Phelps, and P. W. Swaan Involvement of Endocytic Organelles in the Subcellular Trafficking and Localization of Riboflavin J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Huang and P. W. Swaan Riboflavin Uptake in Human Trophoblast-Derived BeWo Cell Monolayers: Cellular Translocation and Regulatory Mechanisms J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 264 - 271. [Abstract] [Full Text] |
||||